Research indicates that Anemoside B4 improves lung function and reduces inflammatory infiltration in COPD mice, possibly by decreasing myeloperoxidase (MPO) levels and ROS production in CSE‐induced human bronchial epithelial cells (HBC) [56]. The gene discussed is MPO; the disease is chronic obstructive pulmonary disease.